Cross-species-specific PSCAxCD3, CD19xCD3, C-METxCD3, EndosialinxCD3, EpCAMxC D3, IGF-1RxCD3 or FAPalpha xCD3 bispecific single chain antibody

Details for Australian Patent Application No. 2009299791 (hide)

Owner Micromet AG

Inventors Kufer, Peter; Raum, Tobias; Kischel, Roman; Lutterbuse, Ralf; Hoffmann, Patrick; Rau, Doris; Klinger, Matthias; Mangold, Susanne; Blumel, Claudia

Agent Pizzeys

Pub. Number AU-A-2009299791

PCT Pub. Number WO2010/037835

Priority 61/101,850 01.10.08 US; 61/101,933 01.10.08 US; 61/101,853 01.10.08 US; 61/101,927 01.10.08 US; 61/101,846 01.10.08 US; 61/101,844 01.10.08 US; 61/101,921 01.10.08 US

Filing date 1 October 2009

Wipo publication date 8 April 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/037835 Priority application(s): WO2010/037835

20 September 2012 Alteration of Name

  The name of the applicant has been altered to Amgen Research (Munich) GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009299792-Cross-species-specific PSMAxCD3 bispecific single chain antibody

2009299790-Package and method of formation